CYTKCytokinetics Inc
CYTK
Cytokinetics Inc4,555
Mkt Cap
$7.7BVolume
985.0052W High
$70.9852W Low
$29.31PE Ratio
-9.57CYTK Fundamentals
Price
$62.50Prev Close
$63.48Open
$63.4450D MA
$63.53Beta
0.91Avg. Volume
1.86MEPS (Annual)
-$6.54P/B
-11.65Rev/Employee
$130,815.75$8,030.25
Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Average Rating of "Moderate Buy" from Brokerages
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) has been assigned an average rating of "Moderate Buy" from the twenty-one ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating...
MarketBeat·2d ago
Why Is Cytokinetics (CYTK) Down 0.8% Since Last Earnings Report?
Cytokinetics (CYTK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·4d ago
E. Ohman J or Asset Management AB Has $23.06 Million Stock Holdings in Cytokinetics, Incorporated $CYTK
E. Ohman J or Asset Management AB lowered its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Free Report) by 10.8% during the fourth quarter, according to its most recent filing with...
MarketBeat·6d ago
Cytokinetics, Incorporated $CYTK Shares Bought by Hudson Bay Capital Management LP
Hudson Bay Capital Management LP lifted its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Free Report) by 15.4% during the 3rd quarter, according to its most recent filing with the...
MarketBeat·10d ago
Cytokinetics (NASDAQ:CYTK) EVP Sells $530,885.30 in Stock
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 8,542 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $62.15, for a total value of $530,885.30. Following the completion of the sale, the executive vice president...
MarketBeat·11d ago
Sung Lee Sells 4,935 Shares of Cytokinetics (NASDAQ:CYTK) Stock
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Sung Lee sold 4,935 shares of the stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $62.15, for a total transaction of $306,710.25. Following the sale, the executive vice president directly...
MarketBeat·12d ago
Insider Selling: Cytokinetics (NASDAQ:CYTK) EVP Sells 1,930 Shares of Stock
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 1,930 shares of the firm's stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $62.07, for a total value of $119,795.10. Following the completion of the sale, the executive vice...
MarketBeat·12d ago
Andrew Callos Sells 8,542 Shares of Cytokinetics (NASDAQ:CYTK) Stock
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 8,542 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $62.15, for a total transaction of $530,885.30. Following the completion of the sale, the...
MarketBeat·12d ago
Fady Ibraham Malik Sells 12,033 Shares of Cytokinetics (NASDAQ:CYTK) Stock
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Fady Ibraham Malik sold 12,033 shares of Cytokinetics stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $62.15, for a total value of $747,850.95. Following the sale, the executive...
MarketBeat·12d ago
Insider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells 36,601 Shares of Stock
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) CEO Robert Blum sold 36,601 shares of the firm's stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $62.15, for a total transaction of $2,274,752.15. Following the sale, the chief executive officer...
MarketBeat·12d ago
<
1
2
...
>